Antenatal screening for Down's syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Alldred, S Kate ^a   Alfirevic, Zarko ^a   Deeks, Jonathan J ^b   Neilson, James P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM 12 PROTEIN; ADAM PROTEIN; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; ECHOGRAPHY; HUMAN; NEURAL TUBE DEFECT; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; REVIEW; SCREENING; SYSTEMATIC REVIEW; URINALYSIS;

EID: 55049140293     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007384     Document Type: Review

References (17)

1. Alfirevic 2003 Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003252]
2. Alfirevic 2004 Alfirevic Z, Neilson JP. Antenatal screening for Down's syndrome. BMJ 2004; Vol. 329, issue 7470:811-2.
3. Bersinger 1995 Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Archives of Gynecology and Obstetrics 1995;256(4):185-92.
4. Bogart 1987 Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenatal Diagnosis 1987;7(9):623-30.
5. Canick 1988 Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. British Journal of Obstetrics and Gynaecology 1988;95(4):330-3.
6. Cole 1999 Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening. Clinical Chemistry 1999;45(12):2109-19.
7. Crossley 2002 Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. British Journal of Obstetrics and Gynaecology 2002;109(6):667-76.
8. Cuckle 1984 Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1984;1(8383):926-9.
9. Cuckle 1987 Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. British Journal of Obstetrics and Gynaecology 1987;94(5):387-402.
10. Cuckle 1995 Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies. Prenatal Diagnosis 1995; Vol. 15, issue 4:385-6.
11. Macri 1990 Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. American Journal of Obstetrics and Gynecology 1990;163(4 Pt 1):1248-53.
12. Macri 1993 Macri JN, Spencer K, Aitken D, Garver K, Buchanan PD, Muller F, et al. First-trimester free beta (hCG) screening for Down syndrome. Prenatal Diagnosis 1993;13(7):557-62.
13. Malone 2005 Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. New England Journal of Medicine 2005;353(19): 2001-11.
14. Merkatz 1984 Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. American Journal of Obstetrics and Gynecology 1984;148(7):886-94.
15. Nicolaides 1992 Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304(6831):867-9.
16. Nicolaides 2005 Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound in Obstetrics and Gynecology 2005;25(3):221-6.
17. Penrose 1933 Penrose LS. The relative effects of parental andmaternal age in mongolism. Journal of Genetics 1933;27:219-24.